Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales
FDA Law Blog
DECEMBER 4, 2023
An extended release (“ER”) opioid in legitimate pain management generally accompanies an IR opioid, with patients taking the ER opioid on a set schedule and the IR opioid as needed. Pharmacists and pharmacy management should pay heed to these prescribing red flags, resolve them when they appear and document their resolution.
Let's personalize your content